Nonmelanoma Skin Cancers, Immunotherapies, and Role of Dermatology Clinicians: A Care Team Forum®

Program Overview

The advent of immunotherapy has transformed dermatologic care, offering hope to patients with advanced NMSC. As the treatment armamentarium expands, clinicians must carefully weigh evolving data in order to optimize outcomes in BCC and CSCC.

Join us for this live webstream to hear our interprofessional expert panel offer privileged insights into evidence-based strategies for the identification of high-risk disease, selection of checkpoint inhibitors, and the management of immune-related adverse events. Uniquely, this panel discussion also features an experienced patient who will augment these insights with teaching moments from their treatment journey.

Credit Expired
0.75 CE Credit(s)
Expires: April 2, 2023

Target Audience

This activity is intended for dermatology and medical oncology clinicians (MD/DO/NP/PA) and all of those who manage patients with advanced nonmelanoma skin cancer (NMSC).

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify high-risk patients with nonmelanoma skin cancer (NMSC) based on current staging systems, risk factors, and guidelines
  • Select appropriate checkpoint inhibitors in the management of patients with advanced NMSC
  • Integrate the unique roles and responsibilities of the interprofessional care team when managing patients with advanced NMSC

Activity Faculty

Patel, Vishal - Headshot

Vishal Anil Patel, MD, FAAD, FACMS (Chair)

Director, Cutaneous Oncology, GW Cancer Center
Director, Dermatologic Surgery, GW Department of Dermatology
Assistant Professor, Dermatology & Hematology/Oncology
Washington, DC

Miller. David - Headshot

David M. Miller, MD, PhD, FAAD

Medical Oncologist, Dermatologist
Massachusetts General Hospital
Director, Center for Merkel Cell Carcinoma
Co-Director, NMSC Multi-Disciplinary Clinic
Department of Medicine, Division of Hematology/Oncology
Department of Dermatology
Massachusetts General Cancer Center
Boston, MA

Rubin, Krista - Headshot

Krista M. Rubin, MS, RN, FNP-BC

Nurse Practitioner, Center for Melanoma
Massachusetts General Hospital
Boston, MA

Supporter Statement

This activity is supported by independent medical education grants from Regeneron Pharmaceuticals, Inc and Sanofi Genzyme

Provider Statement

Disclosure of Financial Relationships

Faculty

Planners and Managers

Method of Participation and Request for Credit

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer Statement

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Copyright Statement

© Copyright 2024. All rights reserved. Developed and managed by RMEI Medical Education, LLC. Laurel Office Plaza | 101 Laurel Road, Suite 200 | Voorhees, NJ 08043 | www.RMEI.com | (866) 770-RMEI

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources